Evidence for the Necessity to Systematically Assess Micronutrient Status Prior to Bariatric Surgery by Ernst, Barbara et al.
RESEARCH ARTICLE
Evidence for the Necessity to Systematically Assess
Micronutrient Status Prior to Bariatric Surgery
Barbara Ernst & Martin Thurnheer &
Sebastian M. Schmid & Bernd Schultes
Received: 26 February 2008 /Accepted: 16 April 2008 /Published online: 20 May 2008
# Springer Science + Business Media, LLC 2008
Abstract
Background Bariatric surgery has been proven the most
effective treatment of morbid obesity, but micronutrient
deficiency following bariatric surgery is a major concern.
Increasing evidence points to a generally poor micronutri-
ent status in obese subjects.
Methods We assessed micronutrient status in 232 morbidly
obese subjects (BMI≥35 kg/m2) prior to bariatric surgery.
Serum albumin, calcium, phosphate, magnesium, ferritin,
hemoglobin, zinc, folate, vitamin B12, 25-OH vitamin D3,
and intact parathormone (iPTH) were determined. In a sub-
sample of 89 subjects, we additionally assessed copper,
selenium, vitamin B1, B3, B6, A, and E levels.
Results Deficiencies were found in 12.5% of the subjects
for albumin, 8.0% for phosphate, 4.7% for magnesium, 6.9%
for ferritin, 6.9% for hemoglobin, 24.6% for zinc, 3.4% for
folate, and 18.1% for vitamin B12. In addition, 25.4%
showed a severe 25-OH vitamin D3 deficiency, which was
accompanied by a secondary hyperparathyroidism in 36.6%
cases. Prevalence of albumin deficiency ( p<0.007) and of
anemia ( p<0.003; in women only) significantly increased
with BMI. Of note, 48.7% of the subjects showed at least
one of the most prevalent deficiencies, i.e., vitamin B12,
zinc and severe 25-OH vitamin D3 deficiency. In the sub-
sample, 32.6% showed a selenium, 5.6% a vitamin B3,
2.2% a vitamin B6, and 2.2% a vitamin E deficiency.
Copper, vitamin B1, and vitamin A deficiency was found in
none of the subjects.
Conclusion Data indicate a high prevalence of micronutri-
ent deficiencies in morbidly obese subjects. Based on these
results, we strongly recommend a systematic assessment of
the micronutrient status in all candidates for bariatric
surgery.
Keywords Morbid obesity .Micronutrient deficiencies .
Preoperative assessment
Introduction
Bariatric surgery has been proven the most effective
treatment of morbid obesity leading not only to a long-
term weight reduction [1, 2] but also to a significant
improvement of health-related quality of life [3] and a
reduction of overall mortality [4, 5]. However, micronutri-
ent deficiency after bariatric procedures is a major concern
[6, 7], which may prevent a physician recommending
morbid obese patients for this effective treatment.
Positive energy balance deriving from excessive food
intake in relation to energy expenditure is the pathophys-
iological basis of obesity in most cases, but the quality of
ingested foods might be poor [8]. Here, the question arises
as to whether in obese subjects micronutrient supply from
consumed foods is sufficient to cover their organism’s
demands. Surprisingly, a quite low number of studies, most
of which are summarized in Table 1, have been carried out
to address this question. Data from the NHANES III
including 3,831 obese subjects indicated a higher likelihood
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of deficiencies in multiple micronutrient components in
subjects with a BMI above 30 kg/m2 as compared with
normal-weight subjects [9]. However, data from that study
do not clarify the question whether the likelihood of
micronutrient deficiencies increases with the severity of
obesity, i.e., with increasing BMI classes. Also, the
majority of studies focusing on morbid obesity (BMI≥
35 kg/m2) only assessed a limited number of micronutrient
components prior to bariatric procedures. For instance,
concentrations of vitamin B3, B6, and copper, deficiencies
of which have in part been attributed to bariatric operations
[10–22], have not yet been systematically studied in
candidates for bariatric surgery prior to the operation.
From the clinical point of view, knowing the prevalence
of micronutrient deficiencies in morbidly obese patients
appears to be of utmost importance. Otherwise, deficiencies
detected after bariatric surgery cannot unequivocally be
attributed to the surgical intervention. Here, we report
results of a comprehensive micronutrient assessment in 232
morbidly obese subjects (BMI≥35 kg/m2) who were
evaluated for bariatric surgery in our Interdisciplinary
Obesity Center.
Methods
In this prospective study, we assessed a comprehensive
micronutrient status in all patients with a BMI of 35 kg/m2
or higher who were referred by their general practitioner or
by themselves to our Interdisciplinary Obesity Center for
evaluation for bariatric surgery between November 2005
and December 2007. Patients who had undergone a
bariatric procedure, e.g., gastric banding, prior to the pre-
sent assessment were excluded from the study. Also,
patients with overt renal function impairment (serum
creatinine concentration >120 μmol/l for men, >100 μmol/l
for women) were excluded from the study, since impaired
renal function is well known to significantly affect vitamin D
metabolism and thereby, PTH levels and calcium homeo-
stasis. All the patients underwent an extensive endocrino-
logical examination in order to detect endocrine disorders
potentially responsible for their obesity, e.g., untreated
hypothyroidism. However, such an endocrine disorder
was detected in none of the subjects. The final sample
included 232 patients. Informed consent was obtained
from all the patients.
Height and weight were measured with patients wearing
light clothing but no shoes. BMI was defined as weight (kg)
divided by height squared (m2). In all the patients, blood
samples were drawn in the morning (8:00–11:00) after an
overnight fast. Micronutrient deficiency was defined as
follows: serum albumin <536.0 μmol/l, serum calcium
<2.0 mmol/l, serum phosphate <0.8 mmol/l, serum magne-
sium <0.7 mmol/l, serum ferritin <18.0 pmol/l, hemoglobin
<8.7 mmol/l for men and <7.5 mmol/l for women, serum
zinc <11.0 μmol/l, serum copper <13.0 μmol/l, serum
selenium <0.9 μmol/l, serum vitamin B1 <933.0 nmol/l,
serum vitamin B3 <65.0 μmol/l, serum vitamin B6 <33.2
nmol/l, serum folate <4.5 nmol/l, serum vitamin B12 <133.0
pmol/l, serum vitamin A <0.7 μmol/l, serum vitamin E
<12.0 μmol/l, serum 25-OH vitamin D3 <76.0 nmol/l (mild
deficiency), <50.0 nmol/l (moderate deficiency), and <25.0
nmol/l (severe deficiency). Serum iPTH >6.5 pmol/l indi-
cated hyperparathyroidism.
Serum copper, selenium, vitamin B1, B3, B6, A, and E
were only assessed in a sub-sample of 89 patients. In all
patients with vitamin B12 deficiency, antibodies against
parietal cells were measured to exclude atrophic gastritis.
However, increased antibody titers could not be detected in
any of the subjects tested.
Data were analyzed by using SPSS 12.1 for Windows
(SPSS, Chicago, IL, USA). To assess the influence of the
degree of obesity, the subjects were grouped according to
their BMI in four groups, i.e., BMI 35 – < 40 kg/m2, BMI
40 – < 45 kg/m2, BMI 45 –< 50 kg/m2 and BMI>50 kg/m2.
Unless otherwise indicated, data are reported as mean±SD.
Variables were compared between different BMI groups by
χ2 test for discrete variables and ANOVA for continuous
variables. For pairwise comparisons, Student’s t test or χ2
test was used. Associations between micronutrient levels
and BMI were evaluated by Pearson’s correlation coeffi-
cient. A p value < 0.05 was considered significant.
Results
The clinical characteristics of the study population are
presented in Table 2. There were no significant differences
in age and height across the four different BMI groups.
Interestingly, the number of evaluated men was higher in
the BMI>40 kg/m2 groups than in the BMI 35–40 kg/m2
group (all p<0.05 for pairwise comparisons).
Table 3 provides data on micronutrients measured in the
entire study population. Overall, below cut-off levels, i.e.,
deficiencies, were found in 12.5% of the subjects for
albumin, 8.0% for phosphate, 4.7% for magnesium, 6.9%
for ferritin, 6.9% for hemoglobin (<8.7 mmol/l in men and
<7.5 mmol/l in women), 24.6% for zinc, 3.4% for folate,
18.1% for vitamin B12, and 89.7% for 25-OH vitamin D3
(<76 nmol/l). In addition, 61.2% of the patients not only
showed a mild but a moderate (<50 nmol/l) and 25.4% even
a severe (<25 nmol/l) 25-OH vitamin D3 deficiency.
According to the high prevalence of 25-OH vitamin D3
deficiency, 36.6% of the patients showed a secondary
hyperparathyroidism with iPTH levels above 6.5 pmol/l. A
primary hyperparathyroidism could be excluded in all the
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patients since none of them showed an increased serum
calcium level.
Analyzing data separately for BMI categories revealed a
significant difference in the prevalence of albumin defi-
ciency ( p=0.007) and hemoglobin deficiency ( p=0.003; in
women) between groups with higher rates of deficiencies
with increasing BMI.
Figure 1 illustrates the distribution of the three most
prevalent deficiencies, i.e., 25-OH vitamin D3 (<25 nmol/l),
vitamin B12, and zinc deficiencies. Subnormal serum values
of at least one parameter were found in 48.7% of the
patients (Fig. 1a). When elevated iPTH levels instead of
25-OH vitamin D3 (<25 nmol/l) were used as an indicator
of 25-OH vitamin D3 deficiency, the number of patients
Table 2 Clinical characteristics of the study population
Total (n=232) BMI (kg/m2) P (trend)
35 –< 40 (n=47) 40 – < 45 (n=87) 45 – < 50 (n=56) >50 (n=42)
Women (%) 71.1 85.1 67.8* 67.9* 66.7* 0.131
Age (y) 40.5±11.6 40.0±11.3 38.9±11.3 42.0±11.3 42.1±12.8 0.344
Height (cm) 166.2±8.7 166.0±7.3 166.6±8.8 166.3±9.2 165.7±9.3 0.952
Weight (kg) 124.3±20.7 104.5±9.1 117.5±13.1 131.6±14.8 150.9±18.1 <0.001
BMI (kg/m2) 44.9±6.2 37.9±1.4 42.2±1.4 47.5±1.5 54.9±4.6 <0.001
Data are the mean±SD, or percentage. P values derive from χ2 test or ANOVA as appropriate.
*P<0.05 vs. BMI group 35 – < 40 by χ2 test.
Table 3 Absolute values and rates of prevalence of deficiency in micronutrients
Total (n=232) BMI P (trend)
35 – < 40 (n=47) 40 – < 45 (n=87) 45 – < 50 (n=56) > 50 (n=42)
Absolute values
Albumin (μmol/l) 612.9±65.2 637.6±66.7 626.0±66.7 597.0±46.4 581.0±66.7 <0.001
Total calcium (mmol/l) 2.3±0.1 2.3±0.1 2.3±0.1 2.2±0.1 2.2±0.1 0.045
Phosphate (mmol/l)a 1.0±0.2 1.0±0.2 1.0±0.2 1.0±0.2 1.0±0.2 0.993
Magnesium (mmol/l)b 0.9±0.1 0.9±0.9 0.9±0.1 0.9±0.2 0.8±0.1 0.708
Ferritin (pmol/l) 165.2±163.8 132.5±122.0 171.1±169.4 200.5±193.4 142.4±143.1 0.145
Hemoglobin (mmol/l) 8.9±0.9 8.9±0.8 9.1±0.7 8.8±0.9 8.7± 1.1 0.123
Zinc (μmol/l) 12.2±1.8 12.3±1.6 12.4±1.9 12.2±1.6 11.9±1.8 0.458
Folate (nmol/l) 13.1±8.4 11.3±4.8 13.6±8.6 14.7±11.3 12.0±6.8 0.170
Vitamin B12 (pmol/l) 202.2±81.9 192.6±73.1 206.5±78.4 218.0±94.4 182.5±78.1 0.144
25-OH-D3 (nmol/l) 47.0±36.4 50.3±28.2 51.1±49.3 44.5±24.5 38.2±23.1 0.241
IPTH (pmol/l) 6.2±2.9 5.4±2.1 5.9±2.5 6.7±3.9 6.9±2.8 0.046
Deficiencies (%)
Albumin <536.0 μmol/l 12.5 8.5 9.2 8.9 28.6 0.007
Phosphate <0.8 mmol/la 8.0 12.8 7.2 5.5 7.7 0.573
Magnesium <0.7 mmol/lb 4.7 4.5 0 10.0 7.5 0.052
Ferritin <18.0 pmol/l 6.9 10.6 4.6 5.4 9.5 0.494
Hemoglobin <8.7 mmol/lc 10.1 15.4 3.0 17.4 10.0 0.313
Hemoglobin <7.5 mmol/ld 5.9 2.0 1.4 8.0 18.8 0.003
Zinc <11.0 μmol/l 24.6 25.5 23.0 17.9 35.7 0.229
Folate <4.5 nmol/l 3.4 0 3.4 5.4 4.8 0.474
Vitamin B12 <133.0 pmol/l 18.1 17.0 16.1 16.1 26.2 0.516
25-OH-D <76.0 nmol/l 89.7 85.1 89.7 89.3 95.2 0.481
25-OH-D <50.0 nmol/l 61.2 53.2 58.6 60.7 76.2 0.139
25-OH-D <25.0 nmol/l 25.4 23.4 20.7 26.8 35.7 0.317
IPTH>6.5 pmol/l 36.6 25.5 36.8 42.9 40.5 0.296
Data are the mean±SD, or percentage. P values derive from χ2 test or ANOVA as appropriate.
aMeasured in 224 patients.
bMeasured in 213 patients.
c For men.
d For women.
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showing at least one alteration in the three parameters was
even higher reaching 56.9% (Fig. 1b). There was no
significant difference in these prevalences across the four
BMI groups ( p=0.390 for the analysis including 25-OH
vitamin D3 and p=0.801 for analysis including iPTH).
Looking at absolute values, there was a clear-cut de-
crease in albumin levels with increasing BMI ( p<0.001).
Total calcium levels were also reduced in the higher as
compared to the lower BMI groups (p=0.045), but this
difference between groups disappeared when calcium levels
were corrected for albumin levels (p=0.113). Also, ferritin,
hemoglobin, vitamin B12, and 25-OH vitamin D3 levels
appeared to decrease with increasing BMI but differences
across BMI groups did not reach significance (all p> 0.14).
However, iPTH levels clearly increase with BMI (p= 0.046)
and correlation analysis confirmed the positive association
between iPTH levels and BMI ( r= 0.191; p=0.004).
Comparison of data between men and women (Table 4)
revealed that, as expected, men were significantly taller and
heavier than women (both p<0.001), but age and BMI was
similar in both sexes (both p>0.34). Women displayed
significant lower albumin (P=0.001), ferritin ( p<0.001),
hemoglobin ( p<0.001), and zinc ( p=0.003) concentrations
than men. Also, prevalence of ferritin deficiency was higher
in women than in men ( p<0.038).
Table 5 provides data on serum copper, selenium,
vitamin B1, vitamin B3, vitamin B6, vitamin A, and vitamin
E levels measured in a subgroup of 89 subjects. Here,
32.6% of the subjects showed a selenium deficiency, 5.6%
a vitamin B3 deficiency, 2.2% a vitamin B6 deficiency, and
2.2% a vitamin E deficiency, while below cut-off levels
were not found for copper, vitamin B1, and vitamin A in
any of the subjects. Mean values for vitamin B1 ( p=0.011)
and vitamin A (p=0.033) were significantly lower in
women than in men, while that of copper were significantly
higher in women ( p<0.001).
Discussion
Present data indicate a high prevalence (>10%) of albumin,
zinc, selenium, vitamin B12, and 25-OH vitamin D3 defi-
ciency as well as elevated iPTH levels in morbidly obese
patients (BMI≥35 kg/m2). In addition, moderate rates of de-
ficiencies (prevalence 5 to 10%) were found for phosphate,
ferritin, hemoglobin, and vitamin B3, and low prevalence
rates (<5%) of deficiencies were found for magnesium,
vitamin B6, folate, and vitamin E levels. None of our patients
showed deficiencies in serum levels of copper, vitamin B1,
and vitamin A. Rates of albumin deficiency and anemia (in
women only) increased with BMI as did absolute iPTH
levels. However, even a substantial number of the patients
within the lowest BMI group (35–40 kg/m2) displayed a
micronutrient deficiency that should not be neglected.
Beside its obvious clinical significance in regard of the
management of bariatric candidates, the present finding of a
high prevalence rate of deficiency in distinct micronutrient
components may also provide broader implications. Here, it
is tempting to speculate that at least some of the found
micronutrient deficiencies contribute to the well-known
health impairing effects of obesity. For instance, vitamin D
deficiency has been found to be associated with an
increased risk for diabetes, cardiovascular diseases, and
several types of cancer [23, 24]. Also, zinc deficiency is
currently suggested to critically promote acute and chronic
liver diseases [25] as well as the development of several
types of cancer [26, 27]. To sum up, the high rate of
micronutrient deficiencies found here strongly calls for
further investigations assessing its potential contribution to
the genesis of diseases being associated with obesity.
Fig. 1 Relationship between zinc, vitamin B12, and 25-OH vitamin
D3 deficiency (a) and between zinc deficiency, vitamin B12 deficiency,
and iPTH elevation (b)
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Table 4 Comparison of absolute values of and deficiencies in micronutrients between men and women
Men (n=67) Women (n=165) P value
Age (year) 41.4±11.4 40.1±11.7 0.436
Height (cm) 174.6±7.3 162.8±6.7 <0.001
Weight (kg) 138.8±19.6 118.5±18.2 <0.001
BMI (kg/m2) 45.5±5.3 44.7±6.5 0.342
Albumin (μmol/l) 634.7±66.7 604.2±62.3 0.001
Albumin <536.0 μmol/l 6.0% 25.0% 0.055
Phosphate (mmol/l)a 1.0±0.2 1.0±0.2 0.666
Phosphate <0.8 mmol/la 10.8% 6.9% 0.336
Magnesium (mmol/l)b 0.9±0.2 0.9±0.1 0.152
Magnesium <0.7 mmol/lb 4.9% 4.6% 0.922
Ferritin (pmol/l) 310.5±204.0 106.2±94.4 <0.001
Ferritin <18.0 pmol/l 1.5% 9.1% 0.038
Hemoglobin (mmol/l) 9.6±0.9 8.6± 0.7 <0.001
Hemoglobin <8.7 mmol/l, <7.5 mmol/lc 10.1 5.9 0.140
Zinc (μmol/l) 12.8±2.0 12.0±1.7 0.003
Zinc <11.0 μmol/l 20.9% 26.1% 0.408
Folate (nmol/l) 12.9±7.0 13.1±9.1 0.893
Folate <4.5 nmol/l 4.5% 3.0% 0.584
Vitamin B12 (pmol/l) 212.8±81.1 197.8±82.1 0.205
Vitamin B12 <133.0 pmol/l 14.9% 19.4% 0.423
25-OH-D3 (nmol/l) 44.3±25.2 48.1±40.1 0.391
25-OH-D3 <76.0 nmol/l 88.1% 90.3% 0.611
25-OH-D3 <50.0 nmol/l 62.7% 60.6% 0.768
25-OH-D3 <25.0 nmol/l 28.4% 24.2% 0.514
iPTH (pmol/l) 6.1±2.3 6.3±3.2 0.514
iPTH>6.5 pmol/l 35.8% 37.0% 0.869
Data are the mean±SD, or percentage. P values derive from χ2 or unpaired Student’s t test as appropriate.
aMeasured in 224 patients.
bMeasured in 213 patients.
c Hemoglobin <8.7 mmol/l for men and <7.5 mmol/l for women.
Table 5 Absolute values and prevalence of deficiency in micronutrients measured only in a sub-sample of the study population
Total (n=89) Men (n=23) Women (n=66) P value
Age (year) 40.7±10.7 41.3±8.3 40.5±11.5 0.719
Height (cm) 166.3±8.1 174.1±7.8 163.6±6.4 <0.001
Weight (kg) 121.2±21.7 138.9±20.6 115.0±18.6 <0.001
BMI (kg/m2) 43.8±6.8 45.8±5.7 43.0±7.1 0.068
Copper (μmol/l) 20.0±4.8 17.3±2.3 21.0±5.0 <0.001
Copper <13.0 μmol/l 0% 0% 0% –
Selenium (μmol/l) 1.1±0.2 1.0±0.2 1.1±0.2 0.286
Selenium <0.9 μmol/l 32.6% 39.1% 30.3% 0.437
Vitamin B1 (nmol/l) 2740±516.7 2956.6±433.3 2663.3±523.3 0.011
Vitamin B1 <933.0 nmol/l 0% 0% 0% –
Vitamin B3 (μmo/l) 155.1±78.8 138.1±53.6 160.8±85.3 0.139
Vitamin B3 <65.0 μmo/l 5.6% 4.3% 6.1% 0.759
Vitamin B6 (nmol/l) 74.1±37.0 80.2 ±45.4 72.1±34.0 0.458
Vitamin B6 <33.2 nmol/l 2.2% 0% 3.0% 0.398
Vitamin A (μmol/l) 3.3±1.0 3.7±0.8 3.2±1.0 0.033
Vitamin A <0.7 μmol/l 0% 0% 0% –
Vitamin E (μmo/l) 36.0±10.7 35.1±10.2 36.2±11.2 0.689
Vitamin E <12.0 μmo/l 2.2% 0% 3.0% 0.398
Data are the mean±SD, or percentage. P values derive from χ2 or unpaired Student’s t test as appropriate.
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Several limitations of our study need to be pointed out.
First, our study population was recruited from patients
referred to our Interdisciplinary Obesity Center for obesity
treatment. Therefore, results obtained here should not be
generalized to a population-based level. Second, deficiency
in micronutrient components may depend on cultural and
geographical factors, and thus, our findings cannot be
generalized to other cultures and geographical regions. For
instance, vitamin D3 production within the skin largely
depends on the amount of sunlight exposure, making
vitamin D3 deficiency more likely to occur in countries
with rare sunshine or cultural limitations to expose large
areas of uncovered skin to the sun. Also, the high number
of selenium deficiencies found in our study most likely
results from the fact that in the region of the Alps, soils
were washed out during the glacial period [28]. Lastly,
since we did not systematically assess micronutrient intake
in the present study, it remains unclear whether the
observed micronutrient deficiencies result from an inade-
quate intake by nutritional habits or other factors that have
not been assessed here.
In conclusion, the present results clearly point to a rather
high prevalence of micronutrient deficiencies in morbidly
obese patients seeking obesity treatment. Although the
clinical significance of most of these deficiencies remains
to be established, based on the present data, we strongly
recommend performing a systematically assessment of
micronutrient status including at a minimum the determi-
nation of albumin, phosphate, ferritin, zinc, selenium,
vitamin B12, 25-OH vitamin D3, iPTH, and vitamin B3 in
candidates for bariatric surgery. Without such an assess-
ment, it will be impossible to straightforwardly attribute
micronutrient deficiencies that are detected after the
operation to the bariatric procedure per se. Also, it can be
assumed that starting a supplementation in regard of
detected deficiencies prior to the bariatric operations yields
beneficial effects.
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